Searched for
US PHARMACEUTICALS EXPANSION
Vegetable prices skyrocketed during Modi Govt's tenure: Telanagana CM Revanth ReddyTelangana Chief Minister Revanth Reddy inaugurated a new fruit market and sub-registrar office complex. He criticized the central governmen...- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Quant Mutual Fund bets on under-owned, under-researched, undervalued and neglected territory stocks for alpha generationQuant Mutual Fund is strategically focusing on under-owned, under-researched, and neglected market segments for higher alpha generation. Th...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Trump administration proposes 25% tariff to punish Brazil over trade practicesThe United States is proposing a 25% tariff on many imports from Brazil. This action follows an investigation into unfair trade practices. ...
- Piyush Goyal engages with over 50 industry leaders in New York to deepen India-US tradeIndia and the United States moved closer to deepening their trade ties as Union Minister of Commerce and Industry Piyush Goyal engaged with...
- Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARRThe company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40...
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...
- Margin pressure, slower growth outlook may cap upside for Sun Pharma stockSun Pharma reported strong revenue and profit growth in the March quarter, but EBITDA margins faced pressure from increased investments and...
- Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formul...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Nifty to hit 42,000 by 2028? New paper that studied market cycles says it's possible if these factors alignA CNI InfoXchange study projects the Nifty could surpass 42,000 by 2028 if sustained foreign investor inflows return. The report highlights...
- Belarus eyes deeper BRICS partnership, strengthens India ties for multipolar worldBelarus eyes full BRICS membership, seeking a multipolar world order. The nation is deepening its strong relationship with India. Key areas...
- Early-stage tech draws VC interest across aviation, biotech, precision manufacturingInvestors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...
- Quad foreign ministers meet in New Delhi to follow Donald Trump's China visitQuad foreign ministers will convene in Delhi to counter China's growing influence, focusing on critical minerals, technology, and supply ch...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Quant Mutual Fund sees ideal time to rebalance portfolios, remains heavily deployed on attractive valuationsQuant Mutual Fund advises aggressive portfolio rebalancing amid improving market conditions, citing attractive valuations and strong liquid...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
Load More
